"An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@en . "im Mai 1997 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . "Kim TS" . "9126973" . . . . "An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@nl . . . "Maecker HT" . "Umetsu DT" . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0442\u0440\u0430\u0432\u043D\u0456 1997"@uk . "scientific article published on 01 May 1997"@en . "An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@en . . . "An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@nl . . "1997-05-01T00:00:00Z"^^ . "Levy S" . "DeKruyff RH" . "158" . "wetenschappelijk artikel"@nl . "4137-4144" . . . . "article scientifique publi\u00E9 en 1997"@fr . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en mayu de 1997"@ast . . "An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@en . "9" . "Rupper R" . . "An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@en . . "An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production"@nl .